US Stem Cell Inc (USRM)

[Parm]

So what it went from 0.01-0.08. Where is the stock now? The stock went up soley on news - it was a classic pump and dump. Why wasn't the news significant enough to keep the stock from dropping from 0.08 to it's current closing PPS? Am I missing something here?

What you're missing is objectivity. I'm a shareholder and at the same time am not emotionally attached to the stock as you are. Even though I've sold most of my shares I still think the technology is great. However - take a look at their financial situation, cash flow, cash on hand and on-going expenses. The company will become insolvent unless they receive major funding. They can't even sustain the Myocell initiative but yet are introducing various other therapies. Where will they receive funding? How will they survive? Can you answer some of these questions for me. I've e-mailed Mike twice about this. He doesn't respond to me because he knows as well as any objective shareholder does that this company is in a lot of financial trouble.

I spoke with my cousin who is a hedgefund manager and he has indicated that Mike Thomas doesn't know anything about Bio-medical aside from raising venture capital for it - that he is renowned for. Look at the management team of Cardio3 ad Mesoblast. Solid bio-tech professionals and doctors. Mike doesn't care - he's getting paid his nice 6 digit salary and taking everyone for a ride.

GLTA - you're gonna need it. This company will file for bankruptcy this year.

AAI